Enliven Therapeutics, Inc.
ELVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001672619
In the last 90 days, Enliven Therapeutics, Inc. insiders filed 0 open-market purchases and 8 sales; 214 institutions reported holding it in 13F filings for Q2 2026, worth $4.06B in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Enliven Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −4 vs. Q4 2021
- Shares held
- 13.9M
- −1.01M (−6.8%) vs. Q4 2021
- Total value
- $26.2M
- −$7.43M (−22.1%) vs. Q4 2021
- New holders
- 2
- 12 more added
- Sold out
- 6
- 11 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 214 | $4.06B |
| Q1 2026 | 171 | $2.43B |
| Q4 2025 | 126 | $960.9M |
| Q3 2025 | 134 | $1.22B |
| Q2 2025 | 125 | $1.19B |
| Q1 2025 | 122 | $983.9M |
| Q4 2024 | 114 | $1.12B |
| Q3 2024 | 102 | $1.22B |
| Q2 2024 | 93 | $1.13B |
| Q1 2024 | 74 | $780.8M |
| Q4 2023 | 62 | $539.8M |
| Q3 2023 | 61 | $533.8M |
| Q2 2023 | 63 | $797.9M |
| Q1 2023 | 45 | $735.0M |
| Q4 2022 | 36 | $74.7M |
| Q3 2022 | 31 | $18.8M |
| Q2 2022 | 26 | $13.1M |
| Q1 2022 | 31 | $26.2M |
| Q4 2021 | 35 | $33.6M |
| Q3 2021 | 38 | $62.5M |
| Q2 2021 | 31 | $86.3M |
| Q1 2021 | 40 | $92.9M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Enliven Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 4,386,568 | $8.25M | 0.13% | 00.0% | Unchanged |
| NEA Management Company, LLC | 3,308,093 | $6.22M | 0.20% | −278,278−7.8% | Reduced |
| Woodline Partners LP | 1,025,017 | $1.93M | 0.03% | +734,581+252.9% | Added |
| Rock Springs Capital Management LP | 842,402 | $1.58M | 0.04% | +1000.0% | Added |
| Lion Point Capital, LP | 834,780 | $1.57M | 0.53% | +834,780 | New |
| Goldman Sachs Group Inc | 833,574 | $1.57M | 0.00% | −10,174−1.2% | Reduced |
| Renaissance Technologies LLC | 450,500 | $847.0K | 0.00% | +10,900+2.5% | Added |
| FMR LLC | 370,159 | $696.0K | 0.00% | −1,639,995−81.6% | Reduced |
| Two Sigma Advisers, LP | 284,000 | $534.0K | 0.00% | +26,200+10.2% | Added |
| Vanguard Group Inc | 265,687 | $500.0K | 0.00% | −218,217−45.1% | Reduced |
| Two Sigma Investments, LP | 244,144 | $459.0K | 0.00% | −18,061−6.9% | Reduced |
| Pura Vida Investments, LLC | 196,635 | $370.0K | 0.04% | +1,100+0.6% | Added |
| Laurion Capital Management LP | 155,183 | $292.0K | 0.01% | −109,498−41.4% | Reduced |
| Bridgeway Capital Management, LLC | 142,000 | $267.0K | 0.01% | +16,800+13.4% | Added |
| Susquehanna International Group, LLP | 118,179 | $222.0K | 0.00% | +81,387+221.2% | Added |
| BlackRock Inc. | 107,396 | $202.0K | 0.00% | +3,601+3.5% | Added |
| Morgan Stanley | 101,934 | $191.0K | 0.00% | −228,847−69.2% | Reduced |
| Bank of New York Mellon Corp | 69,692 | $131.0K | 0.00% | +51,031+273.5% | Added |
| Geode Capital Management, LLC | 54,463 | $102.0K | 0.00% | −314−0.6% | Reduced |
| Tudor Investment Corp Et Al | 51,923 | $98.0K | 0.00% | 00.0% | Unchanged |
| Great Valley Advisor Group, Inc. | 21,011 | $40.0K | 0.00% | −1,600−7.1% | Reduced |
| State Street Corp | 21,198 | $40.0K | 0.00% | 00.0% | Unchanged |
| Prelude Capital Management, LLC | 19,545 | $37.0K | 0.00% | +701+3.7% | Added |
| Northern Trust Corp | 15,314 | $29.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 10,307 | $19.0K | 0.00% | −61,543−85.7% | Reduced |
| Federated Hermes, Inc. | 3,838 | $7.00K | 0.00% | +1,062+38.3% | Added |
| Tower Research Capital LLC (TRC) | 830 | $2.00K | 0.00% | −4,020−82.9% | Reduced |
| Wells Fargo & Company | 78 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 32 | $0 | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 337 | $0 | 0.00% | +39+13.1% | Added |
| Ancora Advisors, LLC | 112 | $0 | 0.00% | +112 | New |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −83,866−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −77,180−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −18,253−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −9,478−100.0% | Sold out |
| Acadian Asset Management LLC | 0 | $0 | 0.00% | −8,592−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −4,485−100.0% | Sold out |